This is consistent with FSHD being a proposed satellite cell-opathy (55,56) and suggests that impaired expansion of myoblasts during regeneration may contribute to the disease pathology in FSHD2 patients. This evidence concerns the gene SMCHD1 and facioscapulohumeral muscular dystrophy.